A detailed history of First Republic Investment Management, Inc. transactions in Biogen Inc. stock. As of the latest transaction made, First Republic Investment Management, Inc. holds 7,209 shares of BIIB stock, worth $1.13 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
7,209
Holding current value
$1.13 Million
% of portfolio
0.01%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023

BUY
$253.3 - $285.89 $1.83 Million - $2.06 Million
7,209 New
7,209 $1.85 Million
Q1 2023

May 11, 2023

SELL
$256.56 - $292.34 $39,253 - $44,728
-153 Reduced 1.33%
11,353 $3.16 Million
Q4 2022

Feb 13, 2023

BUY
$252.44 - $306.72 $363,766 - $441,983
1,441 Added 14.32%
11,506 $3.19 Million
Q3 2022

Nov 03, 2022

SELL
$194.69 - $268.46 $352,388 - $485,912
-1,810 Reduced 15.24%
10,065 $2.69 Million
Q2 2022

Aug 16, 2022

SELL
$187.54 - $223.02 $42,008 - $49,956
-224 Reduced 1.85%
11,875 $2.42 Million
Q1 2022

May 16, 2022

SELL
$193.77 - $244.14 $7,944 - $10,009
-41 Reduced 0.34%
12,099 $2.55 Million
Q4 2021

Feb 09, 2022

SELL
$223.92 - $287.77 $1.24 Million - $1.59 Million
-5,517 Reduced 31.25%
12,140 $2.91 Million
Q3 2021

Nov 12, 2021

BUY
$282.99 - $369.05 $1.78 Million - $2.32 Million
6,293 Added 55.38%
17,657 $5 Million
Q2 2021

Aug 16, 2021

SELL
$259.0 - $414.71 $232,841 - $372,824
-899 Reduced 7.33%
11,364 $3.94 Million
Q1 2021

May 14, 2021

SELL
$242.95 - $284.63 $302,715 - $354,648
-1,246 Reduced 9.22%
12,263 $3.43 Million
Q4 2020

Feb 16, 2021

SELL
$236.26 - $355.63 $1.11 Million - $1.67 Million
-4,684 Reduced 25.75%
13,509 $3.31 Million
Q3 2020

Nov 12, 2020

BUY
$264.77 - $305.71 $1.06 Million - $1.22 Million
4,001 Added 28.19%
18,193 $5.16 Million
Q2 2020

Aug 13, 2020

SELL
$258.66 - $342.55 $5,431 - $7,193
-21 Reduced 0.15%
14,192 $3.8 Million
Q1 2020

May 13, 2020

SELL
$268.85 - $341.04 $455,163 - $577,380
-1,693 Reduced 10.64%
14,213 $4.5 Million
Q4 2019

Feb 14, 2020

SELL
$220.06 - $304.07 $590,200 - $815,515
-2,682 Reduced 14.43%
15,906 $4.72 Million
Q3 2019

Nov 08, 2019

SELL
$217.44 - $243.88 $843,014 - $945,522
-3,877 Reduced 17.26%
18,588 $4.33 Million
Q2 2019

Aug 07, 2019

SELL
$219.29 - $241.72 $5.49 Million - $6.05 Million
-25,022 Reduced 52.69%
22,465 $5.25 Million
Q1 2019

Apr 30, 2019

SELL
$216.71 - $338.96 $3.22 Million - $5.04 Million
-14,870 Reduced 23.85%
47,487 $11.2 Million
Q4 2018

Feb 12, 2019

BUY
$278.5 - $352.75 $17.4 Million - $22 Million
62,357 New
62,357 $18.8 Million
Q3 2018

Nov 13, 2018

SELL
$293.51 - $383.83 $15.6 Million - $20.4 Million
-53,237 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$257.52 - $306.91 $1.59 Million - $1.9 Million
6,190 Added 13.16%
53,237 $15.5 Million
Q1 2018

May 10, 2018

BUY
$260.13 - $367.91 $1.02 Million - $1.44 Million
3,905 Added 9.05%
47,047 $12.9 Million
Q4 2017

Feb 09, 2018

SELL
$307.64 - $344.58 $1.14 Million - $1.28 Million
-3,717 Reduced 7.93%
43,142 $13.7 Million
Q3 2017

Nov 14, 2017

BUY
$281.15 - $329.69 $13.2 Million - $15.4 Million
46,859
46,859 $14.7 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track First Republic Investment Management, Inc. Portfolio

Follow First Republic Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.